Advanced Search

Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2015 February;106(1) > Minerva Medica 2015 February;106(1):45-52

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEMINERVA MEDICA

A Journal on Internal Medicine

Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,236

Frequency: Bi-Monthly

ISSN 0026-4806

Online ISSN 1827-1669

 

Minerva Medica 2015 February;106(1):45-52

ARTIFICIAL ORGANS 

Extracorporeal respiratory support: on the road to an artificial lung

Abrams D., Brodie D.

Division of Pulmonary, Allergy and Critical Care, Columbia University College of Physicians and Surgeons, New York, NY, USA

Extracorporeal membrane oxygenation (ECMO) technology has undergone significant advancement in the last several years. These changes have led to more compact circuits that are increasingly efficient at gas exchange while decreasing the complication rates often associated with its use. The ability to remove carbon dioxide at relatively low flows has broadened the application of ECMO in the management of respiratory failure. As this technology continues to evolve, there is great promise of a portable lung replacement therapy, an artificial lung, which would have far-reaching implications in the approach to both acute and chronic respiratory failure.

language: English


FULL TEXT  REPRINTS

top of page